Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

NCT05532722 is registered in ClinicalTrials.gov with Abcuro, Inc. as lead sponsor.

NCT NCT05532722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05532722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Lead sponsor
Abcuro, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
September 28, 2022
Completion date
March 31, 2026
Enrollment
21 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

t-cell large granular lymphocytic leukemia